[Analysis of Therapeutic Efficacy and Adverse Prognostic Factors of Secondary Central Nervous System Lymphoma].
HD-MTX combined with TMZ as the first-line strategy may improve patient prognosis, and early application of gene sequencing is beneficial for evaluating prognosis.
Authors
- Sichu Liu (ORCID: https://orcid.org/0000-0003-0004-9472)
- Hanguo Guo
- Fei-Li Chen
- Yan Teng (ORCID: https://orcid.org/0000-0003-3817-6696)
- Ning Wang (ORCID: https://orcid.org/0000-0002-4389-2796)
- Wenyu Li (ORCID: https://orcid.org/0000-0002-6444-7149)
- Lu Pan (ORCID: https://orcid.org/0009-0007-8994-6722)
- Ling Huang (ORCID: https://orcid.org/0000-0002-5373-7394)
- Xiaojuan Wei
- Xinmiao Jiang
- Yilan Huang (ORCID: https://orcid.org/0000-0003-1982-5152)
- Zhanli Liang
Institutions
- Shantou University (CN)
- Shantou University Medical College (CN)
- South China University of Technology (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-10-01
- DOI
- https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.05.018
- Primary Topic
- CNS Lymphoma Diagnosis and Treatment
- Type
- article